Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells

被引：67
|
作者：
Chuu, Chih-Pin [1 ]
Chen, Rou-Yu [1 ]
Kokontis, John M. [1 ]
Hiipakka, Richard A. [1 ]
Liao, Shutsung [1 ]
机构：
[1] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA
来源：
CANCER LETTERS | 2009年 / 275卷 / 01期
关键词：
Prostate cancer; LNCaP; EGCG; PSA; Androgen receptor; TEA EPIGALLOCATECHIN GALLATE; GREEN TEA; ATHYMIC MICE; TUMOR-GROWTH; REGULATED ACTIVITY; CARCINOMA-CELLS; CYCLE ARREST; TRAMP MICE; INHIBITION; DEPRIVATION;
D O I：
10.1016/j.canlet.2008.10.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The green tea polyphenol, (-)-epigallocatechin-3-gallate (EGCG), inhibits the development and progression of prostate cancer in TRAMP mice and in men. We examined the effects of EGCG on LNCaP human prostate cancer sublines 104-S, 104-R1 and R1Ad representing different progression stages of prostate cancer. EGCG suppressed cell proliferation, prostate specific antigen (PSA) expression, and AR transcriptional activity in the different LNCaP sublines. Intraperitoneal administration of EGCG also suppressed the growth of relapsing R1Ad tumors and decreased tumor-derived serum PSA. Effects of EGCG on tumor PSA expression have the potential to affect accurate monitoring of patient tumor burden by serum PSA measurements. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：86 / 92
页数：7
相关论文
共 50 条
  • [1] Gene expression profile in human prostate LNCaP cancer cells by (-)epigallocatechin-3-gallate
    Wang, SI
    Mukhtar, H
    CANCER LETTERS, 2002, 182 (01) : 43 - 51
  • [2] Four stages of prostate cancer: Suppression and eradication by androgen and green tea epigallocatechin gallate
    Liao, SS
    Kokontis, JM
    Chuu, CP
    Hsu, S
    Fukuchi, J
    Dang, M
    Hiipakka, RA
    HORMONAL CARCINOGENESIS IV, 2005, : 211 - 220
  • [3] Suppression of metallothionein 3 gene expression by androgen in LNCaP prostate cancer cells
    Otsuka, Takashi
    Hamada, Aki
    Iguchi, Kazuhiro
    Usui, Shigeyuki
    Hirano, Kazuyuki
    BIOMEDICAL REPORTS, 2013, 1 (04) : 614 - 618
  • [4] Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific: Antigen gene in the LNCaP prostate tumour model
    Sato, N
    Gleave, ME
    Bruchovsky, N
    Rennie, PS
    Goldenberg, SL
    Lange, PH
    Sullivan, LD
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1996, 58 (02): : 139 - 146
  • [5] Impact of Androgen Receptor Activity on Prostate-Specific Membrane Antigen Expression in Prostate Cancer Cells
    Sommer, Ulrich
    Siciliano, Tiziana
    Ebersbach, Celina
    Beier, Alicia-Marie K.
    Stope, Matthias B.
    Joehrens, Korinna
    Baretton, Gustavo B.
    Borkowetz, Angelika
    Thomas, Christian
    Erb, Holger H. H.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
  • [6] Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells
    Mitchell, SH
    Zhu, W
    Young, CYF
    CANCER RESEARCH, 1999, 59 (23) : 5892 - 5895
  • [7] Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells
    Xing, NZ
    Chen, Y
    Mitchell, SH
    Young, CYF
    CARCINOGENESIS, 2001, 22 (03) : 409 - 414
  • [8] Epigallocatechin-3-gallate (EGCG) down-regulates the androgen receptor and the IGF pathway in the prostate of TRAMP mice
    Harper, Curt E.
    Patel, Brijesh B.
    Wang, Jun
    Lamartiniere, Coral A.
    CANCER RESEARCH, 2006, 66 (08)
  • [9] Finasteride Upregulates Expression of Androgen Receptor in Hyperplastic Prostate and LNCaP Cells: Implications for Chemoprevention of Prostate Cancer
    Hsieh, Ju-Ton
    Chen, Shyh-Chyan
    Yu, Hong-Jeng
    Chang, Hong-Chiang
    PROSTATE, 2011, 71 (10): : 1115 - 1121
  • [10] Suppression of androgen receptor signaling in prostate cancer cells by an inhibitory receptor variant
    Butler, LM
    Centenera, MM
    Neufing, PJ
    Buchanan, G
    Choong, CSY
    Ricciardelli, C
    Saint, K
    Lee, M
    Ochnik, A
    Yang, M
    Brown, MP
    Tilley, WD
    MOLECULAR ENDOCRINOLOGY, 2006, 20 (05) : 1009 - 1024
12345